The expression of selenium-binding protein 1 is decreased in uterine leiomyoma

<p>Abstract</p> <p>Background</p> <p>Selenium has been shown to inhibit cancer development and growth through the mediation of selenium-binding proteins. Decreased expression of selenium-binding protein 1 has been reported in cancers of the prostate, stomach, colon, and lungs. No information, however, is available concerning the roles of selenium-binding protein 1 in uterine leiomyoma.</p> <p>Methods</p> <p>Using Western Blot analysis and immunohistochemistry, we examined the expression of selenium-binding protein 1 in uterine leiomyoma and normal myometrium in 20 patients who had undergone hysterectomy for uterine leiomyoma.</p> <p>Results and Discussion</p> <p>The patient age ranged from 34 to 58 years with a mean of 44.3 years. Proliferative endometrium was seen in 8 patients, secretory endometrium in 7 patients, and atrophic endometrium in 5 patients. Two patients showed solitary leiomyoma, and eighteen patients revealed 2 to 5 tumors. Tumor size ranged from 1 to 15.5 cm with a mean of 4.3 cm. Both Western Blot analysis and immunohistochemistry showed a significant lower level of selenium-binding protein 1 in leiomyoma than in normal myometrium. Larger tumors had a tendency to show a lower level of selenium-binding protein 1 than smaller ones, but the difference did not reach a statistical significance. The expression of selenium-binding protein 1 was the same among patients with proliferative, secretory, and atrophic endometrium in either leiomyoma or normal myometrium. Also, we did not find a difference of selenium-binding protein 1 level between patients younger than 45 years and older patients in either leiomyoma or normal myometrium.</p> <p>Conclusions</p> <p>Decreased expression of selenium-binding protein 1 in uterine leiomyoma may indicate a role of the protein in tumorigenesis. Our findings may provide a basis for future studies concerning the molecular mechanisms of selenium-binding protein 1 in tumorigenesis as well as the possible use of selenium in prevention and treatment of uterine leiomyoma.</p

Variation in soft tissue chemistry among scyphozoan and cubozoan jellyfishes from the Great Barrier Reef, Australia

Bioaccumulation of trace elements in jellyfish has so far received little attention, despite their being prey for many animals from multiple trophic levels and targeted by commercial jellyfish fisheries. Scyphozoan and cubozoan jellyfish were collected over a three year period from across-shelf and along the northern and central Great Barrier Reef, Australia. To test the hypotheses that jellyfishes were able to accumulate elements above ambient background levels, and if there were spatial or temporal variations among species, soft tissue concentrations of 14 trace elements were compared with ambient seawater concentrations. Most elements, including aluminium, arsenic, barium, cadmium, chromium, copper, iron, manganese and zinc were measured at concentrations above ambient seawater levels indicating bioaccumulative capacity. Results showed some regulation of lithium in Cassiopea sp., Cyanea sp. and Mastigias sp., while calcium, magnesium and strontium reflected ambient conditions for all species. Accumulation varied significantly among species and sampling locations. For Mastigias sp. and Netrostoma sp., tissue concentrations of Al, As, Cu, Fe and Zn decreased with distance from the mainland. The hypothesis that jellyfishes are capable of accumulating trace elements was accepted, and their use as biomonitors should be investigated further